The state of Connecticut currently has 2 active clinical trials seeking participants for COPD research studies. These trials are conducted in various cities, including New Haven, Hartford, Farmington and Stamford.
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
Recruiting
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)
Gender:
ALL
Ages:
Between 40 years and 80 years
Trial Updated:
04/28/2025
Locations: Research Site, New Britain, Connecticut
Conditions: Chronic Obstructive Pulmonary Disease (COPD)
Prospective, Observational Study of Wellinks Effect on COPD Hospital Readmissions
Recruiting
This prospective, observational study is designed to investigate clinical outcomes and collect patient feedback on the use of Wellinks, an integrated virtual chronic obstructive pulmonary disease (COPD) management solution, for patients recently discharged from the hospital due to an acute exacerbation of their COPD.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
10/31/2023
Locations: Hartford Hospital, Hartford, Connecticut
Conditions: COPD, Respiratory Tract Disease, Pulmonary Disease, Chronic Obstructive, Lung Diseases, Obstructive, Lung Diseases